PhRMA
NOVEMBER 15, 2022
You are probably reading a lot about a surge of cases of respiratory viruses like respiratory syncytial virus (RSV), influenza (the flu) and SARS-CoV-2, which causes COVID-19. The triple threat of these highly contagious respiratory viruses circulating simultaneously is causing a ripple of effects on patients, health care providers and our health care system as a whole.
Pharmacy Times
NOVEMBER 15, 2022
Currently, no national pharmacy organization has defined wellness in the pharmacy profession, which is needed so that others have a sense of guidance around wellness within the profession.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 15, 2022
As the Covid-19 pandemic spread across the world two years ago, one of India’s leading biotech companies was racing to develop a vaccine with crucial backing from the Indian government. The shot engineered by Bharat Biotech was, in part, an important effort to create a home-grown product that could bolster the fortunes of the Indian pharmaceutical industry.
Pharmacy Times
NOVEMBER 15, 2022
Anxiety disorders include generalized anxiety, social anxiety, panic disorder, and fear of certain places or situations, including crowds and public transportation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
NOVEMBER 15, 2022
A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users. With the HLTH 2022 event now well underway, digital health industry leaders all gathered together to attend in Las Vegas this week, the juli survey results reveal consumer responses to be more varied than one would have expected when it comes to data privacy.
Pharmacy Times
NOVEMBER 15, 2022
In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 15, 2022
Mirvetuximab soravtansine-gynx (Elahere; ImmunoGen Inc) approved FR?-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Drug Topics
NOVEMBER 15, 2022
Although initial infection of the virus has resulted in risk of hospitalization and mortality, researchers looked into the affects of reinfection as data has been unclear.
pharmaphorum
NOVEMBER 15, 2022
Early on Day 2, Matthew Holt (who we recently featured in our Health Innovators video series ) will interview Walmart EVP Dr. Cheryl Pegus & SCAN Health Plan’s Dr. Sachin Jain. Then we’ll hear from Aptar Digital Health’s Sai Shankar and Pierre Laurent in a session all about patients as partners in healthcare. The day will continue with other hot topics for pharma, including health equity, cell and gene therapy, oncology, and pharmacy model disruption.
Pharmacy Times
NOVEMBER 15, 2022
Dapagliflozin and standard of care found to slow the decline in kidney function and lower the incidence of kidney failure.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 15, 2022
BOSTON — The executives behind Altos Labs would really, really like people to stop saying they’re trying to reverse aging. They have a couple things going against them on this count. For one, the first article about the biotech and its $3 billion stash talked about Silicon Valley billionaires “ living forever.” And then there’s their most prominent scientist’s tendency to talk openly about people living to 130.
Pharmacy Times
NOVEMBER 15, 2022
Approximately 80% of all HIV infections among teens are from the gay and bisexual population.
Fierce Healthcare
NOVEMBER 15, 2022
HLTH22: Google, Epic ink deal to migrate hospital EHRs to the cloud to ramp up use of AI, analytics. hlandi. Wed, 11/16/2022 - 02:42.
Drug Topics
NOVEMBER 15, 2022
The approval extends the use of Liletta for an additional 2 years.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
NOVEMBER 15, 2022
Swiss pharma group Roche has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap into the Boston-based biotech drug discovery platform for a wide-ranging push across cancer, immune-mediated, and neurological diseases. The new agreement – announced on the same day that Jnana finalised a $107 million series C financing – has a potential deal value of around $2 billion and comes two years after Roche paid $40 million upfront with $1 billion at the back-end for a
STAT
NOVEMBER 15, 2022
Medicare Advantage began life as a brilliant idea: a public-private partnership to keep older people healthier and reduce costs. At the time in 1992, both President George H.W. Bush and his challenger, Bill Clinton, supported it. An editorial in The New York Times declared, “The debate over health care reform is over. Managed competition has won.
pharmaphorum
NOVEMBER 15, 2022
Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic. Lockdowns and 25-second handwashing, face masks, home-schooling, and working from home became the new normal. The term “social distancing” entered into common parlance and we transitioned to a life largely spent at home.
PharmaVoice
NOVEMBER 15, 2022
Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts.
The Checkup by Singlecare
NOVEMBER 15, 2022
If you’re one of the 60 million Americans that experience heartburn and indigestion every month, you may find yourself searching for relief and wondering what the best heartburn medicine is. With so many options on the market, it can be hard to know where to start. Whether you’re looking for an over-the-counter heartburn medicine or something a little stronger, it’s important that you find something that works for you because heartburn can be a sign of gastroesophageal reflux.
STAT
NOVEMBER 15, 2022
WHITE OAK, Md. — The Food and Drug Administration, as the name suggests, is supposed to police the United States’ food and drug supply. But there are still illegal products available for easy purchase at gas stations and convenience stores all over the country — including in the FDA’s own backyard. We know, we bought them.
Fierce Healthcare
NOVEMBER 15, 2022
Northwell Health's research arm studied 35,000 COVID patients for years. Using basic data, it built an AI tool to predict outcomes. agliadkovskaya. Tue, 11/15/2022 - 16:23.
Fierce Pharma
NOVEMBER 15, 2022
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court. fkansteiner. Tue, 11/15/2022 - 08:48.
STAT
NOVEMBER 15, 2022
True to its e-commerce expertise, Amazon is jumping into the world of direct-to-consumer telehealth. On Tuesday, the tech goliath launched a virtual health storefront that individuals can access through the main Amazon website and its mobile app, offering the ability to message teleproviders and obtain prescriptions for about 20 health conditions. Amazon has been making significant shifts in its health care strategy in the last few months: In July, it announced plans to acquire primary care comp
Digital Pharmacist
NOVEMBER 15, 2022
The holidays are right around the corner, and we’re here to help ensure you have the best marketing plan in place for your business. We know it’s difficult preparing your pharmacy for the holidays while also properly promoting your services, so we are here to help. . Below we are sharing five tips for creating a successful holiday marketing plan this season. 1.
STAT
NOVEMBER 15, 2022
BOSTON — In science journalism, there’s a well-worn technique reporters reach for when they’re interviewing a researcher and the technical material starts whizzing over their heads. “OK, explain it again, and this time, as if you were talking to your mother.” The conjured image of a parent tends to do just the trick; prompting an illuminating alchemy of clarity infused with excitement.
Fierce Pharma
NOVEMBER 15, 2022
Ardelyx FDA docs portend another showdown at this week's expert hearing on kidney disease prospect. fkansteiner. Tue, 11/15/2022 - 10:30.
Drug Topics
NOVEMBER 15, 2022
A real-world study determined the efficacy of mRNA vaccines for protection against COVID-19 in adolescents.
European Pharmaceutical Review
NOVEMBER 15, 2022
The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. According to IGBA, the World Health Organization ( WHO) Biosimilars Guideline has been a useful tool for health authorities to boost international regulatory convergence and consistency of term
Drug Store News
NOVEMBER 15, 2022
Target reported Q3 GAAP earnings per share of $1.54, down 49.3% from $3.04 in 2021 and adjusted EPS of $1.54, a decrease of 49.1% compared with $3.03 in 2021.
Fierce Healthcare
NOVEMBER 15, 2022
Midwest nonprofits Sanford Health, Fairview Health Services target a 58-hospital merger for 2023. dmuoio. Tue, 11/15/2022 - 13:05.
Drug Topics
NOVEMBER 15, 2022
BLA submission is based on phase 3 trial results evaluating the safety and efficacy of lebrikizumab.
European Pharmaceutical Review
NOVEMBER 15, 2022
Since 1991, GAMP ® – a community of practice within the International Society for Pharmaceutical Engineering (ISPE) – has set the tone for the validation practices necessary for regulated pharmaceutical companies to meet the computerized system expectations of the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the World Health Organization (WHO), the Medicines and Healthcare Regulatory Agency (MHRA) in the UK, the Chinese National Medicinal Products Ad
pharmaphorum
NOVEMBER 15, 2022
On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Now in its seventh year, the Showcase gives life science and healthcare corporates the opportunity to pitch, profile, and connect with investors and partners, alongside masterclasses and dedicated 1:1 partnering.
STAT
NOVEMBER 15, 2022
For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps to widen access to their medicines in low and middle-income countries, but the poorest countries continue to be disproportionately overlooked, according to a new analysis. All 20 of the drugmakers reviewed now have an access-to-medicine strategy, up from 17 previously, and all but one company has integrated access-to-medicine strategies into their overall corporate strategies.
Expert insights. Personalized for you.
302 
Let's personalize your content